Konservative Adipositastherapie

The continuously increasing prevalence of obesity represents one of the most significant health-economic challenges of our century. In recent years, intensified research has not only fundamentally altered the scientific and medical understanding of the disease obesity but has also led to the development of new therapeutic options. Based on the realization that obesity is a disease characterized by alterations in the central nervous system, among the conservative therapeutic options, pharmacotherapy—for example, glucagon-like peptide‑1 (GLP-1) analogs—as well as specific patient education programs and digital health applications (DiGA) are the main foci. In addition to the mentioned treatment approaches, adequate evidence-based patient education and enlightenment concerning the disease are of utmost importance.